The invention relates to methods of using sodium channel modulators, particularly TTX-R sodium channel modulators and/or activity dependent sodium channel modulators to treat a gastrointestinal tract disorders, particularly inflammatory bowel disorders and irritable bowel syndrome.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a divisional of copending U.S. application Ser. No. 10/769,071, filed Jan. 30, 2004; which claims the benefit of U.S. Provisional Application No. 60/443,731, filed Jan. 30, 2003, U.S. Provisional Application No. 60/443,730, filed Jan. 30, 2003, U.S. Provisional Application No. 60/480,565, filed Jun. 20, 2003, U.S. Provisional Application No. 60/480,598, filed Jun. 20, 2003, and U.S. Provisional Application No. 60/495,958, filed Aug. 18, 2003; the contents of which are herein incorporated by reference in their entirety.
